Skip to main content
FinSpry Logo
FinSpry
DNTH logo
DNTH
(NASDAQ)
Dianthus Therapeutics, Inc.
$111.10-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Dianthus Therapeutics (DNTH) Stock Price & Financial Analysis

Dianthus Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$108.95 - $112.72
52-Week High$116.89
52-Week Low$20.69
Open$110.30
Volume730.87K
Average Volume (3M)800.75K
Market Cap5.34B
Shares Outstanding48.03M
Price to Sales (P/S)4129.52
Price to Book (P/B)4.59
EV/EBITDA-450.26
Revenue (TTM)1.34M
Net Income (TTM)-11.32M
Free Cash Flow (TTM)-130.49M
EPS (TTM)$-0.28
Profit Margin-847.53%
Operating Margin-14318.04%
Return on Equity (ROE)-0.94%
Debt to Equity0.00
50-Day MA$97.83
200-Day MA$70.84
52-Week Change453.81%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Dianthus Therapeutics

What is the current stock price for DNTH?

As of the latest trading session, DNTH stock trades at $111.10. The 52-week range is $20.69–$116.89, with a day range of $108.95–$112.72.

What is the P/E ratio for DNTH?

The P/E ratio (Price-to-Earnings) for DNTH is shown in the Key Statistics section. This valuation metric helps compare Dianthus Therapeutics, Inc. to industry peers.

Does DNTH pay dividends?

Dianthus Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for DNTH?

Based on 12 analysts, the consensus for DNTH is Buy.

What is the market cap of DNTH?

Dianthus Therapeutics's market capitalization is $5.34B, classifying it as a mid-cap company. Dianthus Therapeutics operates in the Healthcare sector within the Biotechnology industry.